Top entities: DBV Technologies, Daniel Tassé, Goldman Sachs, Nasdaq, Euronext Paris.

What category does this event fall under?

Business — classified as conference participation.

What is the sentiment of coverage?

Aggregate sentiment score: 10 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

What were the key actions taken?

DBV Technologies announced participation · Daniel Tassé will participate

Is this event still developing?

This is an active story, last updated Jun 05, 2026. Coverage continues to evolve.

Business conference participation

DBV Technologies to attend Goldman Sachs conference

Q: When did this event occur?

First reported Jun 05, 2026; last updated Jun 05, 2026.

Q: What is the market impact?

Direct. The participation of DBV Technologies in the Goldman Sachs 47th Annual Global Healthcare Conference could positively impact its stock price by increasing investor awareness and confidence in its ongoing clinical trials and proprietary VIASKIN patch technology.

Analysis based on 12 articles · First reported Jun 05, 2026 · Last updated Jun 05, 2026

Sentiment

Attention

Articles

Market Impact

Direct

Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard

Market Impact

The participation of DBV Technologies in the Goldman Sachs 47th Annual Global Healthcare Conference could positively impact its stock price by increasing investor awareness and confidence in its ongoing clinical trials and proprietary VIASKIN patch technology. This event provides a platform for Daniel Tassé to communicate the company's progress and future outlook to a broad financial audience.

biotechnology pharmaceuticals

Event Summary

DBV Technologies, a late-stage biopharmaceutical company, announced that its CEO, Daniel Tassé, will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference on June 9, 2026, in Miami, FL. The company, which develops treatments for food allergies using its VIASKIN patch technology, will use this opportunity to engage with the financial community. A live webcast and archived replay of the fireside chat will be available on DBV Technologies' investor website. The company's shares are traded on Euronext Paris and its ADSs on the Nasdaq.

Key Actions

90 DBV Technologies announced participation

80 Daniel Tassé will participate

Entities Involved

stock

DBV Technologies

DBV Technologies will participate in the Goldman Sachs 47th Annual Global Healthcare Conference, providing an opportunity to present its developments and potentially attract investor interest.

Importance 100 Sentiment 10

per

Daniel Tassé

Daniel Tassé, CEO of DBV Technologies, will participate in a fireside chat at the conference, representing the company and its strategic direction.

Importance 70 Sentiment 0

stock

Goldman Sachs

Goldman Sachs is hosting the 47th Annual Global Healthcare Conference, providing a platform for companies like DBV Technologies to engage with the financial community.

Importance 50 Sentiment 0

exch

Nasdaq

DBV Technologies' ADSs are traded on the Nasdaq, making the conference relevant for its investors.

Importance 10 Sentiment 0

exch

Euronext Paris

DBV Technologies' ordinary shares are traded on Euronext Paris, indicating its presence in European markets.

Importance 10 Sentiment 0

NEWSDESK

Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard